TDOC Earnings & Financial Statements
Teladoc Health, Inc.
$5.97
+$0.16(+2.75%)
42
Overall
60
Value
18
Tech
50
Quality
Market Cap
$1.06B
Volume
2.93M
52W Range
$4.40 - $9.89
Target Price
$7.65
TDOC earnings and financial statements: Teladoc Health, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
TDOC Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $2.53B | $2.57B | $2.60B | $2.41B | $2.03B |
| Cost of revenue | $771.59M | $751.27M | $760.03M | $743.99M | $650.26M |
| Operating income | -$262.95M | -$1.02B | -$248.55M | -$13.65B | -$265.63M |
| EBITDA | $160.62M | -$587.01M | $151.40M | -$13.37B | -$83.89M |
| Net income | -$200.32M | -$1.00B | -$220.37M | -$13.66B | -$428.79M |
| EPS (diluted) | $-1.14 | $-5.87 | $-1.34 | $-84.60 | $-2.73 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $2.86B | $3.52B | $4.39B | $4.35B | $17.73B |
| Total liabilities | $1.47B | $2.03B | $2.07B | $2.04B | $1.69B |
| Shareholders’ equity | $1.39B | $1.49B | $2.33B | $2.31B | $16.05B |
| Cash and equivalents | $781.08M | $1.30B | $1.12B | $918.18M | $893.48M |
| Long-term debt | $1.03B | $1.02B | $1.58B | $1.57B | $1.27B |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $294.36M | $293.68M | $350.02M | $189.29M | $193.99M |
| Capital expenditure | -$157.02M | -$124.05M | -$156.35M | -$172.76M | -$63.93M |
| Free cash flow | $137.33M | $169.63M | $193.67M | $16.53M | $130.06M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TDOC | $5.97 | +2.8% | 2.93M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |